Med-tech gainers and losers for Dec. 29, 2025-Jan. 2, 2026

Clinical OMICsFast-Acting Malaria Drug Shows Promise in First-in-Human Study

Clinical OMICsUltrasensitive HPV DNA Blood Test Could Help Personalize Head and Neck Cancer Treatment

Clinical OMICsDigital Portal Strengthens Patient Engagement in Cancer Clinical Trials

Clinical OMICsAI Detects Breast Cancer Much Earlier than Radiologists Alone

FierceBiotechFrom executive assistant to chief executive: Charles River CEO Birgit Girshick on ‘the next big transition’ in the CRO industry

Endpoints NewsParabilis CEO Mathai Mammen on biotech's record IPO

IlluminaCalls of the day: Illumina, Netflix and REITs - MSN

Promega BlogPromega Builds Opportunity to Appreciate Hidden Wetland

FierceBiotechADA: Novo’s Lange says ‘jury still out’ on CagriSema amid tough retatrutide comparisons

BioPharma DiveEthyreal starts up with $101M and takes aim at a pair of immune diseases

Clinical OMICsEngineered Salmonella Delivers Cancer-Killing Virus to Tumors